Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078610143> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2078610143 endingPage "759" @default.
- W2078610143 startingPage "759" @default.
- W2078610143 abstract "Background Multiple sclerosis (MS) is an autoimmune disease with multifactorial etiology. Previous studies showed that HLA-DRB115 allele is a major genetic risk factor for MS in other populations possibly through regulation of vitamin D receptor (VDR) complex. In this study, we investigated the HLA class II genotypes and VDR gene polymorphism among a group of Lebanese MS patients and controls. Methods Fifty MS patients (remitting/relapsing, aged: 19–74years, male:female=1:2.1) were selected for this study, based on the Expanded Disability Status Scale. The controls included: 49 healthy subjects (aged: 15–59years, male:female=1:2) and 51 neurologic patients other than MS (Non-MS, aged 13–70 years, male:female=1:1.12). After a thorough history, blood in EDTA tube was collected. Extracted genomic DNA was used for molecular analysis of VDR genotypes(ApaI, TaqI and BsmI) and HLA class II typing (low resolution HLA-DRB1/3/4/5) (Luminex, San Diego, CA). Differences between groups were evaluated using Mann Whitney-U test. Chi-square test was used for association between various categorical variables (p=0.05); therefore both were combined into one control group for analysis. Frequency of HLA-DRB115 was significantly higher in MS patients compared to controls. None of the VDR gene alleles differed between the two groups. Odds ratio (OR) for MS in the presence of DRB115 allele was 3.21 (p=0.016; 95% CI=1.20–8.59). Cosegregation of HLA-DRB115 and VDR genotypes showed no increase in risk for MS in the presence of A-allele (OR=3.40; p=0.022; 95% CI=1.14–10.19). Similarly, combination of DRB115 with b-allele resulted in higher OR of 4.22 although not statistically significant (p=0.08; 95% CI=0.75–23.89). Conclusion Our results confirm that HLA-DRB115 is a strong predisposing factor for MS in Lebanese patients. Furthermore, the interaction between specific VDR alleles and HLA polymorphism does not significantly increase the susceptibility to MS. Multiple sclerosis (MS) is an autoimmune disease with multifactorial etiology. Previous studies showed that HLA-DRB115 allele is a major genetic risk factor for MS in other populations possibly through regulation of vitamin D receptor (VDR) complex. In this study, we investigated the HLA class II genotypes and VDR gene polymorphism among a group of Lebanese MS patients and controls. Fifty MS patients (remitting/relapsing, aged: 19–74years, male:female=1:2.1) were selected for this study, based on the Expanded Disability Status Scale. The controls included: 49 healthy subjects (aged: 15–59years, male:female=1:2) and 51 neurologic patients other than MS (Non-MS, aged 13–70 years, male:female=1:1.12). After a thorough history, blood in EDTA tube was collected. Extracted genomic DNA was used for molecular analysis of VDR genotypes(ApaI, TaqI and BsmI) and HLA class II typing (low resolution HLA-DRB1/3/4/5) (Luminex, San Diego, CA). Differences between groups were evaluated using Mann Whitney-U test. Chi-square test was used for association between various categorical variables (p=0.05); therefore both were combined into one control group for analysis. Frequency of HLA-DRB115 was significantly higher in MS patients compared to controls. None of the VDR gene alleles differed between the two groups. Odds ratio (OR) for MS in the presence of DRB115 allele was 3.21 (p=0.016; 95% CI=1.20–8.59). Cosegregation of HLA-DRB115 and VDR genotypes showed no increase in risk for MS in the presence of A-allele (OR=3.40; p=0.022; 95% CI=1.14–10.19). Similarly, combination of DRB115 with b-allele resulted in higher OR of 4.22 although not statistically significant (p=0.08; 95% CI=0.75–23.89). Our results confirm that HLA-DRB115 is a strong predisposing factor for MS in Lebanese patients. Furthermore, the interaction between specific VDR alleles and HLA polymorphism does not significantly increase the susceptibility to MS." @default.
- W2078610143 created "2016-06-24" @default.
- W2078610143 creator A5025073896 @default.
- W2078610143 creator A5028368482 @default.
- W2078610143 creator A5033435187 @default.
- W2078610143 creator A5068216512 @default.
- W2078610143 creator A5076347963 @default.
- W2078610143 creator A5076646846 @default.
- W2078610143 date "2014-11-01" @default.
- W2078610143 modified "2023-10-01" @default.
- W2078610143 title "Vitamin D receptor polymorphisms and HLA-class II genotypes among Lebanese with multiple sclerosis – A pilot study" @default.
- W2078610143 doi "https://doi.org/10.1016/j.msard.2014.09.200" @default.
- W2078610143 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25891607" @default.
- W2078610143 hasPublicationYear "2014" @default.
- W2078610143 type Work @default.
- W2078610143 sameAs 2078610143 @default.
- W2078610143 citedByCount "1" @default.
- W2078610143 countsByYear W20786101432015 @default.
- W2078610143 crossrefType "journal-article" @default.
- W2078610143 hasAuthorship W2078610143A5025073896 @default.
- W2078610143 hasAuthorship W2078610143A5028368482 @default.
- W2078610143 hasAuthorship W2078610143A5033435187 @default.
- W2078610143 hasAuthorship W2078610143A5068216512 @default.
- W2078610143 hasAuthorship W2078610143A5076347963 @default.
- W2078610143 hasAuthorship W2078610143A5076646846 @default.
- W2078610143 hasConcept C104317684 @default.
- W2078610143 hasConcept C124490489 @default.
- W2078610143 hasConcept C126322002 @default.
- W2078610143 hasConcept C135763542 @default.
- W2078610143 hasConcept C149737253 @default.
- W2078610143 hasConcept C156957248 @default.
- W2078610143 hasConcept C179639408 @default.
- W2078610143 hasConcept C180754005 @default.
- W2078610143 hasConcept C203014093 @default.
- W2078610143 hasConcept C2779105492 @default.
- W2078610143 hasConcept C2780640218 @default.
- W2078610143 hasConcept C54355233 @default.
- W2078610143 hasConcept C71924100 @default.
- W2078610143 hasConcept C86803240 @default.
- W2078610143 hasConcept C90924648 @default.
- W2078610143 hasConceptScore W2078610143C104317684 @default.
- W2078610143 hasConceptScore W2078610143C124490489 @default.
- W2078610143 hasConceptScore W2078610143C126322002 @default.
- W2078610143 hasConceptScore W2078610143C135763542 @default.
- W2078610143 hasConceptScore W2078610143C149737253 @default.
- W2078610143 hasConceptScore W2078610143C156957248 @default.
- W2078610143 hasConceptScore W2078610143C179639408 @default.
- W2078610143 hasConceptScore W2078610143C180754005 @default.
- W2078610143 hasConceptScore W2078610143C203014093 @default.
- W2078610143 hasConceptScore W2078610143C2779105492 @default.
- W2078610143 hasConceptScore W2078610143C2780640218 @default.
- W2078610143 hasConceptScore W2078610143C54355233 @default.
- W2078610143 hasConceptScore W2078610143C71924100 @default.
- W2078610143 hasConceptScore W2078610143C86803240 @default.
- W2078610143 hasConceptScore W2078610143C90924648 @default.
- W2078610143 hasIssue "6" @default.
- W2078610143 hasLocation W20786101431 @default.
- W2078610143 hasOpenAccess W2078610143 @default.
- W2078610143 hasPrimaryLocation W20786101431 @default.
- W2078610143 hasRelatedWork W1990555669 @default.
- W2078610143 hasRelatedWork W2039071866 @default.
- W2078610143 hasRelatedWork W2058500842 @default.
- W2078610143 hasRelatedWork W2134828080 @default.
- W2078610143 hasRelatedWork W2281456597 @default.
- W2078610143 hasRelatedWork W2351757521 @default.
- W2078610143 hasRelatedWork W2383736357 @default.
- W2078610143 hasRelatedWork W2406127901 @default.
- W2078610143 hasRelatedWork W2510640945 @default.
- W2078610143 hasRelatedWork W4317378737 @default.
- W2078610143 hasVolume "3" @default.
- W2078610143 isParatext "false" @default.
- W2078610143 isRetracted "false" @default.
- W2078610143 magId "2078610143" @default.
- W2078610143 workType "article" @default.